

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.30222149 |
| 2 | protein K11-linked deubiquitination (GO:0035871) | 4.14908163 |
| 3 | cellular response to ethanol (GO:0071361) | 4.00086381 |
| 4 | microglial cell activation (GO:0001774) | 3.96289089 |
| 5 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.77155253 |
| 6 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.73520148 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61933538 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43253513 |
| 9 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.41987549 |
| 10 | hepatocyte apoptotic process (GO:0097284) | 3.36408720 |
| 11 | interkinetic nuclear migration (GO:0022027) | 3.35058176 |
| 12 | protein targeting to lysosome (GO:0006622) | 3.27878437 |
| 13 | establishment of protein localization to vacuole (GO:0072666) | 3.27878437 |
| 14 | protein targeting to vacuole (GO:0006623) | 3.27878437 |
| 15 | establishment of protein localization to Golgi (GO:0072600) | 3.26967588 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.25592488 |
| 17 | mature B cell differentiation involved in immune response (GO:0002313) | 3.24675888 |
| 18 | histone mRNA catabolic process (GO:0071044) | 3.21666670 |
| 19 | positive regulation of mast cell degranulation (GO:0043306) | 3.11982795 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11982795 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.11917130 |
| 22 | neutrophil mediated immunity (GO:0002446) | 3.11068186 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10187046 |
| 24 | mature B cell differentiation (GO:0002335) | 3.09422426 |
| 25 | cellular extravasation (GO:0045123) | 3.07160196 |
| 26 | macrophage activation (GO:0042116) | 3.04411728 |
| 27 | negative regulation of complement activation (GO:0045916) | 3.02913184 |
| 28 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00658886 |
| 29 | protein K63-linked deubiquitination (GO:0070536) | 2.99543538 |
| 30 | protein K48-linked deubiquitination (GO:0071108) | 2.97479647 |
| 31 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96804911 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92568553 |
| 33 | detection of external biotic stimulus (GO:0098581) | 2.91198846 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 2.88453353 |
| 35 | regulation of mast cell activation (GO:0033003) | 2.86441035 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 2.83579748 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 2.83579748 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.83579748 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.83579748 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.83579748 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 2.83579748 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81246132 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.81082512 |
| 44 | fibroblast migration (GO:0010761) | 2.79851666 |
| 45 | response to peptidoglycan (GO:0032494) | 2.79168597 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78313073 |
| 47 | regulation of establishment of cell polarity (GO:2000114) | 2.77442519 |
| 48 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.77213580 |
| 49 | definitive hemopoiesis (GO:0060216) | 2.75349846 |
| 50 | lipid translocation (GO:0034204) | 2.74202975 |
| 51 | phospholipid translocation (GO:0045332) | 2.74202975 |
| 52 | regulation of pigment cell differentiation (GO:0050932) | 2.72815643 |
| 53 | regulation of hypersensitivity (GO:0002883) | 2.68723066 |
| 54 | negative regulation of B cell proliferation (GO:0030889) | 2.66356733 |
| 55 | positive regulation of developmental pigmentation (GO:0048087) | 2.65850116 |
| 56 | protein targeting to Golgi (GO:0000042) | 2.63978735 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 2.63438825 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.61079379 |
| 59 | negative regulation of interleukin-8 production (GO:0032717) | 2.60808821 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 2.59235727 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 2.56902782 |
| 62 | regulation of germinal center formation (GO:0002634) | 2.54400672 |
| 63 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54080721 |
| 64 | myeloid leukocyte mediated immunity (GO:0002444) | 2.52023782 |
| 65 | iron ion import (GO:0097286) | 2.51471586 |
| 66 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.47191050 |
| 67 | regulation of necroptotic process (GO:0060544) | 2.46169815 |
| 68 | T-helper 1 type immune response (GO:0042088) | 2.45572551 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.45345402 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45309193 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44153932 |
| 72 | negative regulation of humoral immune response (GO:0002921) | 2.43871808 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 2.43313647 |
| 74 | detection of biotic stimulus (GO:0009595) | 2.42938153 |
| 75 | histone H3-K4 trimethylation (GO:0080182) | 2.41697618 |
| 76 | response to host immune response (GO:0052572) | 2.41666045 |
| 77 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41666045 |
| 78 | early endosome to late endosome transport (GO:0045022) | 2.41180154 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.38796023 |
| 80 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.36684425 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36091117 |
| 82 | germinal center formation (GO:0002467) | 2.33725768 |
| 83 | negative regulation of interleukin-17 production (GO:0032700) | 2.32974128 |
| 84 | detection of other organism (GO:0098543) | 2.32534308 |
| 85 | response to host (GO:0075136) | 2.31914463 |
| 86 | response to host defenses (GO:0052200) | 2.31914463 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.31914463 |
| 88 | histone H3-K36 demethylation (GO:0070544) | 2.31712997 |
| 89 | gonadal mesoderm development (GO:0007506) | 2.31207056 |
| 90 | regulation of B cell proliferation (GO:0030888) | 2.30112489 |
| 91 | neutrophil activation (GO:0042119) | 2.28647659 |
| 92 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.28071336 |
| 93 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.27333266 |
| 94 | positive regulation of chemokine secretion (GO:0090197) | 2.26630158 |
| 95 | neural tube formation (GO:0001841) | 2.26504776 |
| 96 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.25374599 |
| 97 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.24599781 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.23688905 |
| 99 | protein localization to lysosome (GO:0061462) | 2.23535313 |
| 100 | protein localization to vacuole (GO:0072665) | 2.23535313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76575247 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.66124004 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.61274169 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.69974850 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66023740 |
| 6 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.63281060 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58216205 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.45094771 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28517617 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.25620178 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.21618406 |
| 12 | TP53_16413492_ChIP-PET_HCT116_Human | 2.06017270 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94881341 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92269904 |
| 15 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.92072967 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89374039 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89338198 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88722124 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88026325 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85974268 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79921435 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78864091 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70996533 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70108227 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70041002 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68041840 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64551754 |
| 28 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64393748 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61584327 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59154734 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58861991 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.58114053 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56725070 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54153243 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53978721 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50271415 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50271415 |
| 38 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.49506901 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48105084 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47435010 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46136140 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44894985 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44589033 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41191657 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39439880 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38605279 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38397229 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38311995 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36954187 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35649815 |
| 51 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.33991123 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33275900 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32450666 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31543157 |
| 55 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31381156 |
| 56 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29881596 |
| 57 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29383072 |
| 58 | * MYB_26560356_Chip-Seq_TH2_Human | 1.28915028 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28223149 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27835176 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24860061 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24232132 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22706985 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21802574 |
| 65 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.18405216 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18281252 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18169595 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17335175 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16888719 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16841741 |
| 71 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.16839496 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16539012 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14613673 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14356497 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14291181 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13734966 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13734966 |
| 78 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12847827 |
| 79 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11853518 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11831181 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11334058 |
| 82 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11297779 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11227225 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11106849 |
| 85 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10557469 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10425626 |
| 87 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10393432 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10333032 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10177940 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09389011 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09154136 |
| 92 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08286886 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07677204 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05695879 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05038603 |
| 96 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04265285 |
| 97 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04265285 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04153836 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03640298 |
| 100 | * MYB_26560356_Chip-Seq_TH1_Human | 1.01549160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.24634815 |
| 2 | MP0003724_increased_susceptibility_to | 3.16784254 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.96587557 |
| 4 | MP0008057_abnormal_DNA_replication | 2.46603000 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 2.23696451 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 2.21619668 |
| 7 | MP0000383_abnormal_hair_follicle | 2.16861475 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.16632335 |
| 9 | MP0002009_preneoplasia | 2.12669512 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.02639527 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.00948685 |
| 12 | MP0006054_spinal_hemorrhage | 2.00882228 |
| 13 | MP0001800_abnormal_humoral_immune | 1.88207843 |
| 14 | MP0005275_abnormal_skin_tensile | 1.87927276 |
| 15 | MP0004883_abnormal_blood_vessel | 1.83326434 |
| 16 | MP0005174_abnormal_tail_pigmentation | 1.83091706 |
| 17 | MP0002419_abnormal_innate_immunity | 1.82165083 |
| 18 | MP0000015_abnormal_ear_pigmentation | 1.82165033 |
| 19 | MP0003828_pulmonary_edema | 1.72426255 |
| 20 | MP0005164_abnormal_response_to | 1.71513585 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.69149974 |
| 22 | MP0001545_abnormal_hematopoietic_system | 1.69149974 |
| 23 | MP0010678_abnormal_skin_adnexa | 1.68550506 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.66602236 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.65794765 |
| 26 | MP0005310_abnormal_salivary_gland | 1.65433401 |
| 27 | MP0003045_fibrosis | 1.64224309 |
| 28 | MP0000427_abnormal_hair_cycle | 1.62612452 |
| 29 | MP0000371_diluted_coat_color | 1.62260621 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.58876249 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.57538346 |
| 32 | MP0002723_abnormal_immune_serum | 1.56513804 |
| 33 | MP0004381_abnormal_hair_follicle | 1.52594963 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.51472583 |
| 35 | MP0009764_decreased_sensitivity_to | 1.49961662 |
| 36 | MP0003303_peritoneal_inflammation | 1.48472946 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.44906415 |
| 38 | MP0001958_emphysema | 1.39243107 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.35506026 |
| 40 | MP0008260_abnormal_autophagy | 1.35503802 |
| 41 | MP0005025_abnormal_response_to | 1.34936414 |
| 42 | MP0002405_respiratory_system_inflammati | 1.32650700 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.31785067 |
| 44 | MP0001819_abnormal_immune_cell | 1.31610444 |
| 45 | MP0003195_calcinosis | 1.31598296 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.30375985 |
| 47 | MP0002168_other_aberrant_phenotype | 1.30255506 |
| 48 | MP0001851_eye_inflammation | 1.28132345 |
| 49 | MP0000685_abnormal_immune_system | 1.27463821 |
| 50 | MP0003436_decreased_susceptibility_to | 1.27334058 |
| 51 | MP0003091_abnormal_cell_migration | 1.22930291 |
| 52 | MP0009785_altered_susceptibility_to | 1.22678508 |
| 53 | MP0005408_hypopigmentation | 1.22575669 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.20180601 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.19076733 |
| 56 | MP0009697_abnormal_copulation | 1.18615064 |
| 57 | MP0008004_abnormal_stomach_pH | 1.18343428 |
| 58 | MP0001853_heart_inflammation | 1.18338327 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.18185313 |
| 60 | MP0001790_abnormal_immune_system | 1.16215417 |
| 61 | MP0005387_immune_system_phenotype | 1.16215417 |
| 62 | MP0003252_abnormal_bile_duct | 1.14850992 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.14562427 |
| 64 | MP0004484_altered_response_of | 1.11416301 |
| 65 | MP0002006_tumorigenesis | 1.11074286 |
| 66 | MP0000716_abnormal_immune_system | 1.09843093 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.09726792 |
| 68 | MP0002398_abnormal_bone_marrow | 1.07672835 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.06856770 |
| 70 | MP0004947_skin_inflammation | 1.05774651 |
| 71 | MP0009278_abnormal_bone_marrow | 1.04020353 |
| 72 | MP0006082_CNS_inflammation | 1.03963023 |
| 73 | MP0005647_abnormal_sex_gland | 1.03100651 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.03067858 |
| 75 | MP0000249_abnormal_blood_vessel | 1.00795917 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.99161732 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.93898703 |
| 78 | MP0005171_absent_coat_pigmentation | 0.91652056 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.91584212 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.91460089 |
| 81 | MP0002928_abnormal_bile_duct | 0.89059199 |
| 82 | MP0002722_abnormal_immune_system | 0.88953723 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.87405686 |
| 84 | MP0005671_abnormal_response_to | 0.85232870 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.83040057 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.81585946 |
| 87 | MP0004043_abnormal_pH_regulation | 0.80578656 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.79755080 |
| 89 | MP0005670_abnormal_white_adipose | 0.79323721 |
| 90 | MP0002429_abnormal_blood_cell | 0.77982973 |
| 91 | MP0008469_abnormal_protein_level | 0.77978618 |
| 92 | MP0001873_stomach_inflammation | 0.77631848 |
| 93 | MP0004084_abnormal_cardiac_muscle | 0.77100047 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.76479528 |
| 95 | MP0003279_aneurysm | 0.76122849 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.73462129 |
| 97 | MP0009115_abnormal_fat_cell | 0.72422579 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.70961757 |
| 99 | MP0009763_increased_sensitivity_to | 0.70481967 |
| 100 | MP0003690_abnormal_glial_cell | 0.68042717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent frontal sinuses (HP:0002688) | 3.85807346 |
| 2 | T lymphocytopenia (HP:0005403) | 3.29051643 |
| 3 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.20305296 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.17462580 |
| 5 | Gingival bleeding (HP:0000225) | 3.16613470 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.00825887 |
| 7 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.91027084 |
| 8 | Osteolytic defects of the hand bones (HP:0009699) | 2.91027084 |
| 9 | Periodontitis (HP:0000704) | 2.90015831 |
| 10 | Genetic anticipation (HP:0003743) | 2.88635399 |
| 11 | Prolonged bleeding time (HP:0003010) | 2.81842578 |
| 12 | Fair hair (HP:0002286) | 2.73455415 |
| 13 | Abnormality of the frontal sinuses (HP:0002687) | 2.71751672 |
| 14 | Optic neuritis (HP:0100653) | 2.69287370 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 2.69287370 |
| 16 | Epistaxis (HP:0000421) | 2.66746295 |
| 17 | Orchitis (HP:0100796) | 2.65491890 |
| 18 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.62840220 |
| 19 | Recurrent fungal infections (HP:0002841) | 2.61873618 |
| 20 | Spondylolisthesis (HP:0003302) | 2.61280344 |
| 21 | Abnormality of the axillary hair (HP:0100134) | 2.60104504 |
| 22 | Abnormality of secondary sexual hair (HP:0009888) | 2.60104504 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.59948984 |
| 24 | Pulmonary artery stenosis (HP:0004415) | 2.57262465 |
| 25 | Aortic aneurysm (HP:0004942) | 2.56542166 |
| 26 | Myositis (HP:0100614) | 2.56028690 |
| 27 | Mitral stenosis (HP:0001718) | 2.53267765 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48355067 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48355067 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47912813 |
| 31 | Syringomyelia (HP:0003396) | 2.44505872 |
| 32 | Spinal cord lesions (HP:0100561) | 2.44505872 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.41290922 |
| 34 | Generalized hypopigmentation of hair (HP:0011358) | 2.39539061 |
| 35 | Acute myeloid leukemia (HP:0004808) | 2.38105813 |
| 36 | Stomach cancer (HP:0012126) | 2.38066471 |
| 37 | Papillary thyroid carcinoma (HP:0002895) | 2.37661237 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.32274783 |
| 39 | Eosinophilia (HP:0001880) | 2.31007896 |
| 40 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29881847 |
| 41 | Hematochezia (HP:0002573) | 2.27189739 |
| 42 | Prostate neoplasm (HP:0100787) | 2.27008254 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.24838114 |
| 44 | Widely spaced teeth (HP:0000687) | 2.23719867 |
| 45 | Clumsiness (HP:0002312) | 2.23599223 |
| 46 | Hyperventilation (HP:0002883) | 2.23115397 |
| 47 | Deformed sella turcica (HP:0002681) | 2.22519168 |
| 48 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.21138696 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19054858 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19054858 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19054858 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18857694 |
| 53 | Narrow palate (HP:0000189) | 2.17820691 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.15605203 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.15487786 |
| 56 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.14416218 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14183635 |
| 58 | Thyroiditis (HP:0100646) | 2.12932666 |
| 59 | Recurrent skin infections (HP:0001581) | 2.12398677 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11976846 |
| 61 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.11178624 |
| 62 | Conjunctival telangiectasia (HP:0000524) | 2.11071109 |
| 63 | Abnormality of the sella turcica (HP:0002679) | 2.10884368 |
| 64 | Stomatitis (HP:0010280) | 2.10462417 |
| 65 | Colitis (HP:0002583) | 2.09646959 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.08801760 |
| 67 | Chest pain (HP:0100749) | 2.07618236 |
| 68 | Large earlobe (HP:0009748) | 2.07260284 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.05659397 |
| 70 | Ectropion (HP:0000656) | 2.05314571 |
| 71 | Increased mean platelet volume (HP:0011877) | 2.03822707 |
| 72 | Recurrent viral infections (HP:0004429) | 2.03679635 |
| 73 | Portal hypertension (HP:0001409) | 2.02613034 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02530454 |
| 75 | Aortic dissection (HP:0002647) | 2.00874068 |
| 76 | Gingivitis (HP:0000230) | 1.99920411 |
| 77 | Facial diplegia (HP:0001349) | 1.99513898 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 1.99357009 |
| 79 | Spontaneous hematomas (HP:0007420) | 1.99173997 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 1.98969596 |
| 81 | Arterial thrombosis (HP:0004420) | 1.98270346 |
| 82 | Glucose intolerance (HP:0000833) | 1.97827144 |
| 83 | Hemoptysis (HP:0002105) | 1.97496544 |
| 84 | Gaze-evoked nystagmus (HP:0000640) | 1.96464900 |
| 85 | Menorrhagia (HP:0000132) | 1.92319280 |
| 86 | Keratoconjunctivitis (HP:0001096) | 1.91839208 |
| 87 | Abnormality of the pericardium (HP:0001697) | 1.91664677 |
| 88 | Absent speech (HP:0001344) | 1.90102666 |
| 89 | Pulmonary infiltrates (HP:0002113) | 1.89855001 |
| 90 | Gangrene (HP:0100758) | 1.89425387 |
| 91 | Abnormal platelet volume (HP:0011876) | 1.88909109 |
| 92 | Leukocytosis (HP:0001974) | 1.87169239 |
| 93 | Granulocytopenia (HP:0001913) | 1.84320331 |
| 94 | Viral hepatitis (HP:0006562) | 1.83787742 |
| 95 | Prominent nose (HP:0000448) | 1.83195394 |
| 96 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.81847411 |
| 97 | Macular degeneration (HP:0000608) | 1.81837367 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.80518652 |
| 99 | Anhidrosis (HP:0000970) | 1.80191934 |
| 100 | Abnormality of T cells (HP:0002843) | 1.80176430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.84814804 |
| 2 | BLK | 3.48813972 |
| 3 | TAOK3 | 3.46950865 |
| 4 | BMPR1B | 2.82131507 |
| 5 | AKT3 | 2.71270818 |
| 6 | PIK3CG | 2.54680355 |
| 7 | BMPR2 | 1.99504989 |
| 8 | IKBKE | 1.91558616 |
| 9 | ACVR1B | 1.76979270 |
| 10 | IRAK1 | 1.75208917 |
| 11 | SGK2 | 1.67896929 |
| 12 | TXK | 1.61547377 |
| 13 | FLT3 | 1.59729462 |
| 14 | KIT | 1.56713495 |
| 15 | MAP3K14 | 1.53183722 |
| 16 | IKBKB | 1.50017095 |
| 17 | NEK9 | 1.49689059 |
| 18 | LATS1 | 1.47816879 |
| 19 | TRPM7 | 1.45996305 |
| 20 | PTK2B | 1.45313651 |
| 21 | JAK1 | 1.44231457 |
| 22 | GRK6 | 1.42009113 |
| 23 | PIK3CA | 1.39690018 |
| 24 | TEC | 1.35562524 |
| 25 | MARK3 | 1.32214724 |
| 26 | NUAK1 | 1.31054123 |
| 27 | JAK3 | 1.30430277 |
| 28 | SYK | 1.27580247 |
| 29 | BTK | 1.23016258 |
| 30 | MAP2K3 | 1.19563943 |
| 31 | GRK7 | 1.19506072 |
| 32 | TGFBR2 | 1.18290235 |
| 33 | TYK2 | 1.17854889 |
| 34 | MAP4K2 | 1.17512810 |
| 35 | CSF1R | 1.16659875 |
| 36 | ZAP70 | 1.14173631 |
| 37 | SGK3 | 1.11930539 |
| 38 | CDK12 | 1.09686788 |
| 39 | MELK | 1.07866840 |
| 40 | CSK | 1.07790834 |
| 41 | NLK | 1.05076731 |
| 42 | CAMK1D | 1.00598439 |
| 43 | CHUK | 0.98932703 |
| 44 | STK38L | 0.98342743 |
| 45 | MYLK | 0.97199829 |
| 46 | MAPK7 | 0.94866266 |
| 47 | BRSK2 | 0.94256543 |
| 48 | CAMK1G | 0.93308679 |
| 49 | HCK | 0.92729708 |
| 50 | CAMKK2 | 0.89944380 |
| 51 | PDGFRB | 0.89419565 |
| 52 | MAP3K3 | 0.88125988 |
| 53 | FER | 0.87827727 |
| 54 | CSNK1A1L | 0.85450099 |
| 55 | STK38 | 0.83711686 |
| 56 | ERBB2 | 0.82878085 |
| 57 | LCK | 0.81473769 |
| 58 | ADRBK1 | 0.79392154 |
| 59 | WNK1 | 0.79233067 |
| 60 | LYN | 0.75767279 |
| 61 | MAP3K2 | 0.75197118 |
| 62 | JAK2 | 0.74454868 |
| 63 | FGR | 0.74229072 |
| 64 | EPHA3 | 0.72349268 |
| 65 | MAP3K7 | 0.71821171 |
| 66 | BRD4 | 0.71010257 |
| 67 | SGK223 | 0.70967531 |
| 68 | SGK494 | 0.70967531 |
| 69 | IRAK4 | 0.69739978 |
| 70 | EGFR | 0.69221366 |
| 71 | TBK1 | 0.68044037 |
| 72 | STK24 | 0.65515234 |
| 73 | PIM1 | 0.61720611 |
| 74 | HIPK2 | 0.60242067 |
| 75 | CDK6 | 0.58171796 |
| 76 | FES | 0.57591134 |
| 77 | RIPK4 | 0.57324011 |
| 78 | ABL1 | 0.56460773 |
| 79 | PRKAA2 | 0.55529853 |
| 80 | MAP3K13 | 0.54506532 |
| 81 | ADRBK2 | 0.54229767 |
| 82 | TNK2 | 0.54034774 |
| 83 | ITK | 0.53174129 |
| 84 | MATK | 0.52951418 |
| 85 | INSRR | 0.52872999 |
| 86 | MARK2 | 0.52306796 |
| 87 | YES1 | 0.51905673 |
| 88 | NEK6 | 0.51627632 |
| 89 | GRK5 | 0.49849172 |
| 90 | PLK2 | 0.49593731 |
| 91 | FGFR3 | 0.49344301 |
| 92 | STK3 | 0.49025767 |
| 93 | MST4 | 0.48894339 |
| 94 | DYRK3 | 0.48532230 |
| 95 | MAP3K1 | 0.48253358 |
| 96 | GRK1 | 0.46237470 |
| 97 | MAPK11 | 0.46226696 |
| 98 | MET | 0.43780641 |
| 99 | PIM2 | 0.43208697 |
| 100 | MAP3K6 | 0.42109764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52820897 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.45086130 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17764838 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16425839 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02506994 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.92860706 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92122460 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76120589 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76032888 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75796721 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71976508 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68383502 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.67403346 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.62883970 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58559073 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.52237478 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.51306241 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45097881 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43704698 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42533714 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42525900 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40127897 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38375743 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21964037 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.21613739 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.18314082 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17064027 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13971853 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.10699323 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09614686 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.09344261 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08633191 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07011790 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06397630 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05005638 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01221526 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.00819327 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00283484 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99502901 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98381906 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96303724 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 0.96216073 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94839052 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94225880 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91540463 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91510078 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91245487 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89669128 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87030558 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87000555 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86192173 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.85312450 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84794854 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82840608 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81814741 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80084978 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.79788745 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78738523 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78684135 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75699155 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.75266621 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75083852 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74327801 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74060937 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73106509 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.72657882 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72593166 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71548579 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.71052160 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67790455 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67720840 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64700943 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64435923 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63394497 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63208858 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62970174 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62906171 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61838674 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.61412766 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.61144001 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.58434285 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.58375101 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58280795 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55671339 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53808908 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53663518 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53561082 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.53139572 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52624198 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50872034 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49634967 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49570633 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47031000 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46853027 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.46248516 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46198794 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45631226 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45614629 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45175438 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44373197 |

